Latest Neurogenesis Stories
When developing babies are growth restricted in the womb, they are typically born with heads that are large relative to their bodies.
ROCKVILLE, Md., Aug. 3, 2011 /PRNewswire/ -- Neuralstem, Inc. (NYSE Amex: CUR) announced it received a U.S. Department of Defense (DOD) contract to develop its human neural stem cell technology for the treatment of cancerous brain tumors.
New research may help to explain why the location of postnatal neural stem cells in the brain determines the type of new neurons that are generated.
ROCKVILLE, Md., July 21, 2011 /PRNewswire/ -- Neuralstem, Inc. (NYSE Amex: CUR) announced that it has received a patent covering the transplantation of human neural cells for the treatment of neurodegenerative conditions from the Russian Federation.
ROCKVILLE, Md., July 14, 2011 /PRNewswire/ -- Neuralstem, Inc. (NYSE Amex: CUR) announced that it has received notice of allowance for U.S.
Duke University Medical Center researchers have found that a "fountain of youth" that sustains the production of new neurons in the brains of rodents is also believed to be present in the human brain.
Stem cell therapy may restore cognition in patients with brain cancer who experience functional learning and memory loss often associated with radiation treatment.
University of Florida scientists have discovered a way to separate the neural wheat from the chaff during the process of generating brain cells for potential patient therapies.
ROCKVILLE, Md., June 20, 2011 /PRNewswire/ -- Neuralstem, Inc. (NYSE Amex: CUR) announced that it has been approved to dose the final cohort in the ongoing Phase Ia trial to test the safety of NSI-189 for the treatment of major depression.
Scientists have known for years that neurogenesis takes place throughout adulthood in the hippocampus of the mammalian brain.
- a meat pie that is usually eaten at Christmas in Quebec